Black Rock Inc. Marker Therapeutics, Inc. Transaction History

Black Rock Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$0.24 - $4.58 $2,407 - $45,941	10,031 Added 8.54%	127,546 $34,000
Q3 2022 Nov 14, 2022	SELL	$0.3 - $3.73 $1,033 - $12,846	-3,444 Reduced 2.85%	117,515 $43,000
Q2 2022 Aug 12, 2022	SELL	$0.26 - $0.46 $36,767 - $65,049	-141,412 Reduced 53.9%	120,959 $40,000
Q1 2022 May 12, 2022	SELL	$0.37 - $1.0 $2,171 - $5,868	-5,868 Reduced 2.19%	262,371 $115,000
Q4 2021 Feb 10, 2022	BUY	$0.95 - $1.72 $8,725 - $15,798	9,185 Added 3.55%	268,239 $255,000
Q3 2021 Nov 09, 2021	BUY	$1.68 - $2.88 $840 - $1,440	500 Added 0.19%	259,054 $438,000
Q2 2021 Aug 11, 2021	BUY	$1.88 - $3.56 $486,081 - $920,452	258,554 New	258,554 $722,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $163M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.